InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and ...
Q3 2025 Management View CEO Tarun Lal stated the company is seeing substantive progress on its Back to Basics plan, highlighting sequential improvement in same-store sales each month of the quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback